320000.KQ Loading...

Loading chart...
Top Calls
Feed
Sources✓
YouTube✓
Twitter✓
Reddit✓
Substack✓
Insider✓
Loading...
0 selected
All Content✓
Source feeds
Buzzberg Top 50 ✓
All market capsNo capitalization filter✓
200 B and aboveMega✓
10 B to 200 BLarge✓
2 B to 10 BMid✓
0 to 2 BSmall✓
Custom
Enter market cap range in B USD
All directions✓
▲ Long✓
▼ Short✓
⛔ Avoid✓
✂ Close✓
◦ Others✓
Any score✓
LOW+✓
MED+✓
HIGH✓
? ?
03:15
Jul 03
Kim Dahye Senior Researcher, Hana Securities Research Center 3PRO TV (삼프로TV)
Injectable aesthetic companies show strong earnings potential.
K-Aesthetics companies, specifically injectables like L&C Bio, PharmaResearch, and Hugel, have strong earnings and exports but their stock prices have lagged. L&C Bio is targeting US/China expansion, PharmaResearch is doing well with Rejuran, and Hugel is starting direct sales in the US. Avoid energy-based devices due to potential inventory issues.
320000.KQ 1ST
HIGH

About 320000.KQ Analyst Coverage

Buzzberg tracks 320000.KQ across 1 sources. 0 bullish vs 0 bearish calls from 1 analysts. Sentiment: evenly split. 1 total trade ideas tracked. Latest voices: Kim Dahye.